ArticleBrain topography2025
Neurophysiological Markers of Auditory Verbal Hallucinations in Patients with Schizophrenia: An EEG Microstates Study.
Article in Brain topography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Alterations in the temporal characteristics of EEG microstates in patients with schizophrenia (SCZ) have been repeatedly found in previous studies. Nevertheless, altered temporal characteristics of EEG microstates in auditory verbal hallucinations (AVHs) SCZ are still unknown. This study aimed to investigate whether SCZ patients with sAVHs exhibit abnormal EEG microstates. We analyzed high-density electroencephalography data that from 79 SCZ patients, including 38 severe AVHs patients (sAVH group), 17 moderate auditory verbal hallucinations patients (mid-AVH group), and 24 without auditory verbal hallucinations patients (non-AVH group). Microstates were compared between three groups. Microstate C exhibited significant differences in duration and coverage and microstate B exhibited significant differences in occurrence between patients with sAVHs and without AVHs. There was a significant negative correlation between the coverage in microstate C and the severity of sAVH. Microstate C in duration, microstate B in occurrence were efficient in detecting sAVH patients. The decreased class C microstates in duration and coverage and increased class B microstates in occurrence may contribute to the severity of symptoms in AVH patients. Furthermore, we have identified that microstates C could serve as potential neurophysiological markers for detecting AVHs in SCZ patients. These results can provide potential avenues for therapeutic intervention of AVHs.
Indexed as
Identifiers
39920494What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.